Table 6.
Genotype and allele frequencies of RANTES -28C/G in Beijing Chinese patients and controls*
SNP | Control (n = 367) | SARS (n = 356) | OR (95% CI) | P |
Number (%) | ||||
Genotype | ||||
RANTES -403 | NS | |||
AA | 60 (16.4) | 62 (17.4) | ||
AG | 160 (43.6) | 153 (43.0) | ||
GG | 147 (40.1) | 141 (39.6) | ||
RANTES -28 | NS | |||
CC | 273 (74.4) | 258 (72.5) | ||
CG | 83 (22.6) | 87 (24.4) | ||
GG | 11 (3.0) | 11 (3.1) | ||
RANTES ln1.1 | NS | |||
CC | 54 (14.7) | 63 (17.7) | ||
CT | 162 (44.1) | 152 (42.7) | ||
TT | 151 (41.1) | 141 (39.6) | ||
Allele | ||||
RANTES -403 | NS | |||
A | 280 (38.2) | 277 (38.9) | ||
G | 454 (61.9) | 435 (61.1) | ||
RANTES -28 | NS | |||
C | 629 (85.7) | 603 (84.7) | ||
G | 105 (14.3) | 109 (15.3) | ||
RANTES ln1.1 | NS | |||
C | 270 (36.8) | 278 (39.0) | ||
T | 464 (63.2) | 434 (60.9) |
NS = not significant.
P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex and age.